<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blurbs &#187; Pharma</title>
	<atom:link href="http://stockblurbs.com/category/pharma/feed/" rel="self" type="application/rss+xml" />
	<link>http://stockblurbs.com</link>
	<description>Stocks and Financial News</description>
	<lastBuildDate>Wed, 09 Sep 2009 10:14:47 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Vivus shares higher in pre-market on positive Qnexa results</title>
		<link>http://stockblurbs.com/2009/09/09/vivus-shares-higher-in-pre-market-on-positive-qnexa-results/</link>
		<comments>http://stockblurbs.com/2009/09/09/vivus-shares-higher-in-pre-market-on-positive-qnexa-results/#comments</comments>
		<pubDate>Wed, 09 Sep 2009 10:14:47 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Headlines]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Diet drugs]]></category>
		<category><![CDATA[Qnexa]]></category>
		<category><![CDATA[Vivus]]></category>
		<category><![CDATA[VVUS]]></category>
		<category><![CDATA[Weight Loss Drug]]></category>

		<guid isPermaLink="false">http://stockblurbs.com/?p=28</guid>
		<description><![CDATA[Vivus shares were up in after-market trading on positive data from two late-stage clinical trials of Qnexa, an experimental treatment for weight loss, before trading begins Wednesday morning. The oral treatment is the Mountain View, Calif.-based company&#8217;s lead product.
NASDAQ:VVUS
]]></description>
			<content:encoded><![CDATA[<p>Vivus shares were up in after-market trading on positive data from two late-stage clinical trials of Qnexa, an experimental treatment for weight loss, before trading begins Wednesday morning. The oral treatment is the Mountain View, Calif.-based company&#8217;s lead product.</p>
<p><a href="http://www.google.com/finance?client=ob&amp;q=NASDAQ:VVUS">NASDAQ:VVUS</a></p>
]]></content:encoded>
			<wfw:commentRss>http://stockblurbs.com/2009/09/09/vivus-shares-higher-in-pre-market-on-positive-qnexa-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
